2kbc
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Solution structure of human insulin-like peptide 5 (INSL5)== | ==Solution structure of human insulin-like peptide 5 (INSL5)== | ||
| - | <StructureSection load='2kbc' size='340' side='right'caption='[[2kbc | + | <StructureSection load='2kbc' size='340' side='right'caption='[[2kbc]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2kbc]] is a 2 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2KBC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2KBC FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[2kbc]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli_BL21(DE3) Escherichia coli BL21(DE3)]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2KBC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2KBC FirstGlance]. <br> |
| - | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> |
| - | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene>, <scene name='pdbligand=PCA:PYROGLUTAMIC+ACID'>PCA</scene></td></tr> |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2kbc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2kbc OCA], [https://pdbe.org/2kbc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2kbc RCSB], [https://www.ebi.ac.uk/pdbsum/2kbc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2kbc ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2kbc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2kbc OCA], [https://pdbe.org/2kbc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2kbc RCSB], [https://www.ebi.ac.uk/pdbsum/2kbc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2kbc ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/INSL5_HUMAN INSL5_HUMAN] May have a role in gut contractility or in thymic development and regulation. Activates RXFP4 with high potency and appears to be the endogenous ligand for this receptor. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 24: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Haugaard-Jonsson | + | [[Category: Haugaard-Jonsson LM]] |
| - | [[Category: Rosengren | + | [[Category: Rosengren KJ]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Solution structure of human insulin-like peptide 5 (INSL5)
| |||||||||||
